Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

10.04

+1.58 (18.68%)

At close: Oct 10, 2025, 4:00 PM EDT

9.82

-0.22 (-2.19%)

After-hours: Oct 10, 2025, 7:59 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	620	427	283	375	950	-
Market Cap Growth	83.38%	50.68%	-24.53%	-60.50%	-	-
Enterprise Value	370.6	93.71	93.76	156.4	604.19	26.07
Last Close Price	10.04	6.94	5.65	7.61	20.42	-
PE Ratio	34.13	-7.08	-2.15	-3.31	-6.90	0
PS Ratio	4.63	5.64	-	-	-	-
PB Ratio	2.31	1.91	1.58	1.38	2.73	0
P/TBV Ratio	3.08	2.30	1.62	1.32	1.47	-
P/FCF Ratio	26.00	11.23	-4.51	-3.56	-13.75	0
P/OCF Ratio	22.37	10.16	-6.47	-4.06	-16.01	0
EV/Sales Ratio	2.08	1.24	-	-	-	-
EV/EBITDA Ratio	15.91	-1.28	-0.68	-1.44	-8.54	-0.95
EV/EBIT Ratio	24.77	-1.16	-0.65	-1.39	-8.29	-0.93
EV/FCF Ratio	15.54	2.47	-1.49	-1.48	-8.74	-0.99
Debt / Equity Ratio	0.14	0.17	0.24	0.16	0	0
Debt / EBITDA Ratio	1.77	-0.58	-0.34	-0.43	-	-
Debt / FCF Ratio	1.72	1.12	-0.73	-0.45	-	-
Asset Turnover	0.45	0.20	0	0	0	0
Quick Ratio	7.00	2.37	5.00	10.58	20.80	1.42
Current Ratio	7.16	2.40	5.07	10.79	20.96	1.49
Return on Equity (ROE)	13.29%	-33.60%	-59.77%	-35.06%	-49.51%	73.63%
Return on Assets (ROA)	4.31%	-21.05%	-44.25%	-31.71%	-35.06%	-56.73%
Return on Capital (ROIC)	12.99%	-57.75%	-180.94%	-257.49%	-337.96%	-109.99%
Return on Capital Employed (ROCE)	4.99%	-30.10%	-49.94%	-33.72%	-39.42%	-139.33%
Earnings Yield	3.90%	-14.12%	-46.55%	-30.22%	-14.50%	-
FCF Yield	3.85%	8.90%	-22.18%	-28.07%	-7.27%	-
Buyback Yield / Dilution	0.00%	-23.32%	-9.75%	-5.55%	-25.04%	-
Total Shareholder Return	-	-23.32%	-9.75%	-5.55%	-25.04%	-

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q